In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections

Mai Banakhar,1 Ahmed Yamani2 1Urology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Urology Department, King Abdulaziz University, Jeddah, Saudi ArabiaCorrespondence: Mai BanakharUrology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box: 215089...

Full description

Bibliographic Details
Main Authors: Banakhar M, Yamani A
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Research and Reports in Urology
Subjects:
Online Access:https://www.dovepress.com/in-patients-with-neurogenic-detrusor-overactivity-and-hinmans-syndrome-peer-reviewed-fulltext-article-RRU
_version_ 1818646237570662400
author Banakhar M
Yamani A
author_facet Banakhar M
Yamani A
author_sort Banakhar M
collection DOAJ
description Mai Banakhar,1 Ahmed Yamani2 1Urology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Urology Department, King Abdulaziz University, Jeddah, Saudi ArabiaCorrespondence: Mai BanakharUrology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box: 215089, Jeddah, Saudi ArabiaTel +966 593435049Fax +966 126408222Email drmaibanakher@hotmail.comPurpose: To study the effect of intravesical Botox injection on the incidence of recurrent symptomatic UTI in neurogenic bladder patients with detrusor overactivity.Patients and Methods: This was a prospective cohort study for patients who received Botox intravesical injection. We included patients with neurogenic bladder with detrusor overactivity and symptomatic recurrent UTI. We compared the number of symptomatic UTIs at six months pre- and post-intravesical Botox injection. Patient files were reviewed for diagnosis, vesico-uretric reflux, hydronephrosis, urodynamic findings pre- and post-injection, and dose of Botox used. Patients were followed for the number of symptomatic UTIs post-Botox injection.Results: There were 93 patients diagnosed with neurogenic detrusor overactivity and symptomatic recurrent UTI. Patients were categorized into three categories: Group 1 – adults, Group 2 – pediatrics, Group 3 – non-neurogenic neurogenic bladder (Hinman’s syndrome). Spina bifida was diagnosed in 22 adults (Group 1) and 32 pediatric patients (Group 2). After receiving Botox injection, 75% of all patients (70) had a significant decrease in number of symptomatic UTIs. Urodynamic tests post-injection showed an improvement in bladder capacity, compliance, and detrusor pressure versus baseline in all three groups. Correlation analysis showed significant correlation between decreased symptomatic UTI post-Botox injection and detrusor pressure post-injection as well as bladder compliance; p-value=0.01 and p=0.021, respectively.Conclusion: Intravesical Botox injection may decrease incidence of symptomatic UTI in neurogenic detrusor overactivity. This effect seemed to be related to better bladder management.Keywords: neurogenic detrusor overactivity, intravesical Botox injections, symptomatic urinary tract infections, neurogenic bladder, recurrent UTI
first_indexed 2024-12-17T00:43:27Z
format Article
id doaj.art-0a5351a1907c495ab8f2b69ac826d3dc
institution Directory Open Access Journal
issn 2253-2447
language English
last_indexed 2024-12-17T00:43:27Z
publishDate 2021-09-01
publisher Dove Medical Press
record_format Article
series Research and Reports in Urology
spelling doaj.art-0a5351a1907c495ab8f2b69ac826d3dc2022-12-21T22:09:57ZengDove Medical PressResearch and Reports in Urology2253-24472021-09-01Volume 1365966368465In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract InfectionsBanakhar MYamani AMai Banakhar,1 Ahmed Yamani2 1Urology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Urology Department, King Abdulaziz University, Jeddah, Saudi ArabiaCorrespondence: Mai BanakharUrology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box: 215089, Jeddah, Saudi ArabiaTel +966 593435049Fax +966 126408222Email drmaibanakher@hotmail.comPurpose: To study the effect of intravesical Botox injection on the incidence of recurrent symptomatic UTI in neurogenic bladder patients with detrusor overactivity.Patients and Methods: This was a prospective cohort study for patients who received Botox intravesical injection. We included patients with neurogenic bladder with detrusor overactivity and symptomatic recurrent UTI. We compared the number of symptomatic UTIs at six months pre- and post-intravesical Botox injection. Patient files were reviewed for diagnosis, vesico-uretric reflux, hydronephrosis, urodynamic findings pre- and post-injection, and dose of Botox used. Patients were followed for the number of symptomatic UTIs post-Botox injection.Results: There were 93 patients diagnosed with neurogenic detrusor overactivity and symptomatic recurrent UTI. Patients were categorized into three categories: Group 1 – adults, Group 2 – pediatrics, Group 3 – non-neurogenic neurogenic bladder (Hinman’s syndrome). Spina bifida was diagnosed in 22 adults (Group 1) and 32 pediatric patients (Group 2). After receiving Botox injection, 75% of all patients (70) had a significant decrease in number of symptomatic UTIs. Urodynamic tests post-injection showed an improvement in bladder capacity, compliance, and detrusor pressure versus baseline in all three groups. Correlation analysis showed significant correlation between decreased symptomatic UTI post-Botox injection and detrusor pressure post-injection as well as bladder compliance; p-value=0.01 and p=0.021, respectively.Conclusion: Intravesical Botox injection may decrease incidence of symptomatic UTI in neurogenic detrusor overactivity. This effect seemed to be related to better bladder management.Keywords: neurogenic detrusor overactivity, intravesical Botox injections, symptomatic urinary tract infections, neurogenic bladder, recurrent UTIhttps://www.dovepress.com/in-patients-with-neurogenic-detrusor-overactivity-and-hinmans-syndrome-peer-reviewed-fulltext-article-RRUneurogenic detrusor overactivityintravesical botox injectionssymptomatic urinary tract infectionsneurogenic bladderrecurrent uti
spellingShingle Banakhar M
Yamani A
In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
Research and Reports in Urology
neurogenic detrusor overactivity
intravesical botox injections
symptomatic urinary tract infections
neurogenic bladder
recurrent uti
title In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
title_full In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
title_fullStr In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
title_full_unstemmed In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
title_short In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
title_sort in patients with neurogenic detrusor overactivity and hinman rsquo s syndrome would intravesical botox injections decrease the incidence of symptomatic urinary tract infections
topic neurogenic detrusor overactivity
intravesical botox injections
symptomatic urinary tract infections
neurogenic bladder
recurrent uti
url https://www.dovepress.com/in-patients-with-neurogenic-detrusor-overactivity-and-hinmans-syndrome-peer-reviewed-fulltext-article-RRU
work_keys_str_mv AT banakharm inpatientswithneurogenicdetrusoroveractivityandhinmanrsquossyndromewouldintravesicalbotoxinjectionsdecreasetheincidenceofsymptomaticurinarytractinfections
AT yamania inpatientswithneurogenicdetrusoroveractivityandhinmanrsquossyndromewouldintravesicalbotoxinjectionsdecreasetheincidenceofsymptomaticurinarytractinfections